Figure 3
From: Immunoprognostic model of lung adenocarcinoma and screening of sensitive drugs
Evaluation of the independent prognostic ability of the risk scoring model. (a) Results of univariate COX regression of risk scores with clinical information in the training set. (b) Results of multi-factor COX regression of risk scores and clinical information in the training set. (c) Results of univariate COX regression in the test set. (d) Results of multifactor COX regression in the test set.
